LaSalle Woman 'Let Down' by Diluted Chemo Drug Settlement
A LaSalle woman says a settlement for a class action lawsuit related to diluted chemotherapy drugs is not enough.
The settlement brought before the courts indicates there was no malicious intent on behalf of the defendants in preparing the drugs. The defendants also deny any suggestion of physical harm to the affected patients, stressing there is no clinical evidence proving the claim.
Sarah Johnson is one of those patients.
She was diagnosed with breast cancer in 2012.
The settlement dishes out $1.8-million to the nearly 1,200 patients affected by the diluted drugs who did not opt-out of the class action lawsuit. The total amount of money each person is expected to receive is roughly $1,500.
The single mother of three says it's not about cashing in.
"It's not about the money, then people are going to say well then ok, just take the $1,500, it's not about that, It is about not letting this ever happen again," Johnson says. "Who learns from having to pay $1,500 dollars to somebody? Unfortunately the only way companies learn from mistakes is through their pocket books."
The dilution issue dates back to February 2012, when Johnson says she needed it the most.
"When you first get cancer, it's devastating news, but then you get that mentality that, no, I'm going to beat it, it's ok. So I'm going to do the Chemo," she says. "When you learn that it has come back a second time, it is the most devastating of all news because you know it is the difference between life and death."
But Johnson says the outcome is the most disappointing news of all.
"You know, there has been a lot of people working really hard on this and trying," says Johnson. "I feel let down."
A further $400,000 is to be paid by the defendants to cover legal fees for those pursuing the lawsuit while $100,000 will be paid to the Ontario and New Brunswick health insurers.
Johnson says she and 49 other plaintiffs could possibly seek independent council and opt out of the settlement.